- Konbuyu başlatan
- #1
- 2 Ocak 2024
- 25
- 0
- 1
- 26
The global anticonvulsants market size was USD 18.16 Billion in 2021 and is expected to register a revenue CAGR of 2.3% during the forecast period, according to latest analysis by Emergen Research. Rising high-value investments in the healthcare sector along with increasing Research & Development (R&D) initiative by various major pharmaceutical companies for improvement in anticonvulsant therapy tolerability and drugs are major factors driving market revenue growth. In addition, rising incidences of epilepsy and various neurological disorders along with growing need for pain management caused by migraines are contributing to growth of the anticonvulsants market.
The report titled ‘Global Anticonvulsants Market’ provides the reader with a panoramic view of the Anticonvulsants industry while estimating the overall size and the size and share of the market’s key regional segments over the projected timeframe. According to our market analysts, the global Anticonvulsants market is expected to exhibit a robust growth rate throughout the forecast period. The promising market growth can be attributed to the significant rise in product demand across the regional markets.
Request a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/1213
Competitive Terrain:
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Anticonvulsants market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
The leading market contenders listed in the report are:
GSK Group of Companies, Novartis AG, Pfizer Inc., UCB S.A, Johnson & Johnson Services, Inc., Abbott, Sunovion Pharmaceuticals Inc., Jazz Pharmaceuticals, Inc., Eisai Co., Ltd., and Sanofi.
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/anticonvulsants-market
Emergen Research has segmented the global Anticonvulsants market on the basis of type, application, end-use, and region:
Segments Covered in this report are:
The report titled ‘Global Anticonvulsants Market’ provides the reader with a panoramic view of the Anticonvulsants industry while estimating the overall size and the size and share of the market’s key regional segments over the projected timeframe. According to our market analysts, the global Anticonvulsants market is expected to exhibit a robust growth rate throughout the forecast period. The promising market growth can be attributed to the significant rise in product demand across the regional markets.
Request a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/1213
Competitive Terrain:
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Anticonvulsants market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
The leading market contenders listed in the report are:
GSK Group of Companies, Novartis AG, Pfizer Inc., UCB S.A, Johnson & Johnson Services, Inc., Abbott, Sunovion Pharmaceuticals Inc., Jazz Pharmaceuticals, Inc., Eisai Co., Ltd., and Sanofi.
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/anticonvulsants-market
Emergen Research has segmented the global Anticonvulsants market on the basis of type, application, end-use, and region:
Segments Covered in this report are:
- Drug Type Outlook (Revenue, USD Billion; 2019-2030)
- α-Amino-3-Hydroxy-5-Methyl-4-isoxazole Propionic acid (AMPA)
- N-Methyl-D-Aspartate Receptor (NMDAR)
- Carbamate Anticonvulsants
- Barbiturate
- Carbonic Anhydrase Inhibitor
- Triazine
- Others
- Drug Generation Outlook (Revenue, USD Billion; 2019-2030)
- First Generation
- Second Generation
- Third Generation
- Distribution Channel Outlook (Revenue, USD Billion; 2019-2030)
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
- Analysis and estimation of the Anticonvulsants Market size and share for the projected period of 2022-2030
- Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
- Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Anticonvulsants Market
- Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
- Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities